Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide has shown promising results in clinical studies for weight management and glycemic control applications.
Our tirzepatide for sale is produced under strict quality control standards, ensuring high purity (≥99%) and consistent batch-to-batch quality. The peptide is supplied in lyophilized form in sterile glass vials, suitable for research purposes.
Tirzepatide works by activating both GIP and GLP-1 receptors, which enhances insulin secretion, suppresses glucagon secretion, and slows gastric emptying. These combined effects contribute to its potential benefits for metabolic research.
Key research applications of tirzepatide include: metabolic syndrome studies, obesity research, diabetes management investigations, and appetite regulation experiments. The peptide has demonstrated superior efficacy compared to single receptor agonists in clinical trials.
For research use only. Not for human consumption. This product should be handled by qualified professionals in laboratory settings only.
